Cargando…
Stretching the limits of antiarrhythmic drug therapy: The promise of small-conductance calcium-activated potassium channel blockers()
Autores principales: | Heijman, Jordi, Rahm, Ann-Kathrin, Dobrev, Dobromir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645440/ https://www.ncbi.nlm.nih.gov/pubmed/34917752 http://dx.doi.org/10.1016/j.ijcha.2021.100924 |
Ejemplares similares
-
Emerging Antiarrhythmic Drugs for Atrial Fibrillation
por: Saljic, Arnela, et al.
Publicado: (2022) -
Recent Advances in Antiarrhythmic Drug Therapy
por: Saljic, Arnela, et al.
Publicado: (2023) -
Pleiotropic Effects of Antiarrhythmic Agents: Dronedarone in the Treatment of Atrial Fibrillation
por: Heijman, Jordi, et al.
Publicado: (2013) -
Ion channels as part of macromolecular multiprotein complexes: Clinical significance
por: Heijman, Jordi, et al.
Publicado: (2017) -
Antiarrhythmic calcium channel blocker verapamil inhibits trek currents in sympathetic neurons
por: Herrera-Pérez, S., et al.
Publicado: (2022)